Studies on new proteins involved in vascular endothelial injury
Studies on new proteins involved in vascular endothelial injury
批准号:
09680607
负责人:
MIYATA Toshiyuki
金额:
$1.86万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
同型半胱氨酸水平升高与动脉硬化和血栓形成有关。同型半胱氨酸可能促进血管疾病的机制尚未阐明。我们在人脐静脉内皮细胞(HUVEC)中发现了一种新的同型半胱氨酸反应蛋白RTP。多种内质网应激诱导剂如衣霉素、A23187和thapsigargin可使其mRNA水平升高。细胞因子对RTP基因的表达影响很小或没有影响。用重组RTP抗血清进行Western印迹分析表明,在未处理的HUVEC中检测到RTP(47 KDa)的蛋白水平,而在同型半胱氨酸或衣霉素处理的细胞中检测到RTP蛋白水平的增加。研究还表明,RTP被部分磷酸化,并含有7个或更多的磷酸化位点。Forsklin处理可促进RTP的磷酸化,而蛋白激酶A抑制剂则抑制RTP的磷酸化。此外,蛋白激酶A在体外可直接磷酸化重组RTP。在增殖的细胞中,磷酸化形式丰富,并且随着细胞密度的增加而减少。免疫细胞化学分析表明,RTP主要定位于培养细胞的胞浆中。免疫组织化学结果显示,RTP在小鼠肾近端小管和肠绒毛中大量表达。目前的研究提出,高同型半胱氨酸血症患者的细胞功能可能通过改变RTP的表达水平及其磷酸化状态而改变。
英文摘要
An elevated level of homocysteine is associated with arteriosclerosis and thrombosis. The mechanisms by which homocysteine may promote vascular diseases have not been elucidated yet. We identified a novel homocysteine responsive protein, RTP, in human umbilical vein endothelial cells (HUVEC). Its mRNA was increased by a variety of endoplasmic reticulum-stress inducing agents such as tunicamycin, A23187, and thapsigargin. Cytokines had little or no effect on RTP mRNA expression. Western blot analysis using recombinant RTP antiserum showed that protein level of RTP (47 kDa) was detectable in untreated HUVEC and increased in homocysteine- or tunicamycin-treated cells. It was also demonstrated that RTP was partially phosphorylated and contained seven or more phosphorylation sites. Phosphorylation of RTP was enhanced by the forskolin treatment and inhibited by a protein kinase A inhibitor. Furthermore, protein kinase A directly phosphorylated recombinant RTP in vitro. The phosphorylated forms were abundant in the proliferating cells and decreased in relation to increased cell density. Immunocytochemical analysis indicated that RTP was mainly located in the cytoplasm of cultured cells. Immunohistochemistry of mouse tissues demonstrated that RTP was present abundantly in proximal tubule of kidney and in villi of intestine. The present study raises the possibility that cellular functions in patients with hyperhomocysteinemia might be altered through changes in the RTP expression level and its phosphorylation state.
期刊论文(52)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
宮田敏行: "「The Frontiers of Strokology,脳卒中学」" 医学書院, 16 (1998)
宫田敏之:“中风学的前沿” Igakushoin,16(1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Fujimura: "Pltelet glycoprotein IIIaPlA polymorphism and Japanese patients with venous thrombosis." Blood Coagl.Fibrinol.9. 449-450 (1998)
H.Fujimura:“血小板糖蛋白 IIIaPlA 多态性与日本静脉血栓形成患者。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Kokame: "“Non-radioactive differential display cloning of genes induced by homocysteine in vascular endothelial cells. "" Methods. 16. 434-443 (1998)
K.Kokame:“血管内皮细胞中同型半胱氨酸诱导的基因的非放射性差异显示克隆。”Methods. 16. 434-443 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
宮田敏行: "Annual Review 血液1998。" 中外医学社, 9 (1998)
宫田俊之:《年度回顾血液 1998》,9 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Miyata: "Genetic analysis of protein C deficiency in nineteen Japanese families : Five recurrent defects can explain half of the deficiencies." Thromb Res.92. 181-187 (1998)
T.Miyata:“十九个日本家庭蛋白质 C 缺乏症的基因分析:五种反复出现的缺陷可以解释一半的缺陷。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 38 条
Genetic background of thrombophilia using third generation DNA sequencing
-
批准号:19K08875
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2019
-
负责人:MIYATA Toshiyuki
-
依托单位:
Production and analysis of Adamts13-Bac-TRAP mice that express fluorescent protein EGFP driven by Adamts13 promoter
-
批准号:23659494
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:MIYATA Toshiyuki
-
依托单位:
Thrombosis due to dysfunction of anticoagulant activity and strategy for prevention of thrombosis
-
批准号:20390278
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2008
-
负责人:MIYATA Toshiyuki
-
依托单位:
A Comprehensive Study of Production, Rice milling, Export and Consumption of Thai Jasmine Rice
-
批准号:18530197
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.68万
-
财政年份:2006
-
负责人:MIYATA Toshiyuki
-
依托单位:
Studies on causative gene for thrombotic thrombocytopenic purpura, ADAMTS13
-
批准号:17390285
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.51万
-
财政年份:2005
-
负责人:MIYATA Toshiyuki
-
依托单位:
Functional analysis of endoplasmic reticulum stress-induced genes, NDRG1 and HERPUD1
-
批准号:15570107
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2003
-
负责人:MIYATA Toshiyuki
-
依托单位:
Political Economy of Thai "Jasmine" Rice
-
批准号:15530201
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.09万
-
财政年份:2003
-
负责人:MIYATA Toshiyuki
-
依托单位:
Studies on genes involved in endothelial dysfunction involved in thrombosis and atherosclerosis
-
批准号:10044337
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$4.16万
-
财政年份:1998
-
负责人:MIYATA Toshiyuki
-
依托单位:
Studies on genes involved in thrombois on endothelial cells
-
批准号:08044333
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$4.67万
-
财政年份:1996
-
负责人:MIYATA Toshiyuki
-
依托单位:
Studies on the initiation of extrinsic blood coagulation reaction
-
批准号:07680665
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1995
-
负责人:MIYATA Toshiyuki
-
依托单位:
New and rapid diagnostic method for cardiovascular disease and prothrombotic state
-
批准号:06557063
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$4.54万
-
财政年份:1994
-
负责人:MIYATA Toshiyuki
-
依托单位:
Three-Dimensional Structure of Human Tissue Factor
-
批准号:05680539
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1993
-
负责人:MIYATA Toshiyuki
-
依托单位:
Study on the extrinsic blood coagulation
-
批准号:03680151
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1991
-
负责人:MIYATA Toshiyuki
-
依托单位:
Structural Studies on Functional Abnormality of Fibrinogen and Factor IX
-
批准号:01571236
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1989
-
负责人:MIYATA Toshiyuki
-
依托单位:
海外基金